[ 7 ] Ubbink JB, van der Merwe A, Delport R, et al. The Effect of a Subnormal Vitamin B-6 Status on Homocysteine Metabolism[J]. J Clin Invest, 1996, 98 (1): 177-184.
[2]
[ 8 ] Kai S, Nomura A, Morishima Y, et al. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly[J]. Arch Gerontol Geriatr, 2006, 42(2):117-124.
[3]
[ 9 ] Yan SK, Chang T, Wang H, et al. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells[J]. Biochem Biophys Res Commun, 2006, 315(2): 485-491.
[4]
Geng BL, Pan CC, Qi Y, et al. Endogenous hydrogen sulde regulation of myocardial injury induced by isoproterenol[J]. Biochem Biophys Res Commun, 2004, 318(3): 756-763.
[5]
Chen YH, Wang PP, Wang XM, et al. Involvement of endogenous hydrogen sulde in cigarette smoke-induced changes in airway responsiveness and inammation of rat lung[J]. Cytokine, 2011, 53(3): 334-341.
[6]
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2007, 176(6): 532-555.
[7]
Jiang Z, Liang Q, Luo G, et al. HPLC？electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy[J]. Talanta, 2009, 77(4): 1279-1284.
[8]
Kitano S, Kanno T, Maekawa M, et al. Improved method for the immunological detection of malondialdehyde-modied low-density lipoproteins in human serum[J]. Anal Chim Acta, 2004, 509(2): 229-235.
[9]
Zhao WM, Zhang J, Lu YJ, et al. The vasorelaxant effect of H2S as a novel endogenous gaseous Katp channel opener[J].Embo J, 2001, 20(21): 6008-6016.
[10]
Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis[J]. Thorax, 2004, 59(7): 574-580.
[11]
Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1997, 156(2): 341-357.
[12]
Robert E, Jemma B, Martin G, et al. Systemic inflammation and COPD[J]. Chest, 2008, 133(1): 19-25.
[13]
Kuleci S, Hanta I, Kocabas A, et al. The effect of different treatment modalities on oxidative stress in COPD[J]. Adv Ther, 2008, 25(7): 710-717.
[14]
Gumral N, Naziroglu M, Ongel K, et al. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods[J]. Cell Biochem Funct, 2009, 27(5): 276-283.
[15]
Karadag F, Cldag O, Altnsk M, et al. Trace elements as a component of oxidative stress in COPD[J]. Respirology, 2004, 9(1): 33-37.
[16]
Seemungal TA, Lun JC, Jin HF, et al. Plasma homocysteine is elevated in COPD patients and is related to COPD severity[J]. Int J Chron Obstruct Pulmon Dis, 2007, 2(3): 313-321.
[17]
Wei HL, Zhang CY, Jin HF, et al. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats[J]. Acta Pharmacologica Sinica, 2008, 29(6): 670-679.
[18]
[ 1 ] Bai N, Khazaei M, Van Eeden SF, et al. The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction[J]. Pharmacol Ther, 2007, 113(1): 16-29.
[ 3 ] Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice[J]. J Clin Invest, 2004, 114(9): 1248-1259.
[21]
[ 4 ] Donma O, Donma MM. Relationship of senescence of pulmonary system to chronic obstructive pulmonary disease in the advanced life[J]. Med Hypotheses, 2002, 59(2): 208-211.
[22]
[ 5 ] Rahman I. Antioxidant therapies in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2006, 1(1): 15-29.
[23]
[ 6 ] Rahman I, Macnee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary diseases[J]. Thorax 1996, 51(4): 348-350.
